Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pizer and its partner BioNTech announced plans on Wednesday to develop a vaccine that will work against SARS-CoV-2 (the virus that causes COVID-19) and the entire class, or family, of related coronaviruses.
COVID-19 vaccines for children 6 months and older are now available through community health centers, according to the Joint Information Center.
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses Pfizer Inc. (NYSE: PFE) and BioNTech
Pfizer and BioNTech announced that their two Omicron-targeted vaccines are safe and effective against the coronavirus, including the latest Omicron subvariants. This new formulation could be used as a fourth shot — or a second booster — to better protect against another coronavirus surge expected this fall and winter.
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent